0001958244-24-000011.txt : 20240102
0001958244-24-000011.hdr.sgml : 20240102
20240102171758
ACCESSION NUMBER: 0001958244-24-000011
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 24503501
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaen Juan C.
CENTRAL INDEX KEY: 0001422996
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
144
1
primary_doc.xml
144
0001422996
XXXXXXXX
LIVE
0001724521
Arcus Biosciences, Inc.
001-38419
3928 Point Eden Way
Hayward
CA
94545
1-510-694-6200
Juan Jaen
Officer
Class A Common Stock
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
100000
1968000
74855565
01/02/2024
NYSE
Class A Common Stock
05/08/2015
Acquired from issuer in private transaction
The issuer
N
100000
05/08/2015
None
Y
The sales of shares set forth herein are made in connection with a selling plan dated 08-Aug-2023 that is intended to comply with Rule 10b5-1(c).
01/02/2024
08/08/2023
Goldman Sachs & Co. LLC on behalf of Juan Jaen